Cargando…
Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial
BACKGROUND: Although the antioxidant properties of ginger have been revealed, there is little available information on the effectiveness of ginger on inflammatory disorders such as atherosclerosis. This study was carried out to examine the effect of ginger on improving the complication of atheroscle...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867307/ https://www.ncbi.nlm.nih.gov/pubmed/33598035 http://dx.doi.org/10.22122/arya.v16i4.2011 |
_version_ | 1783648272810770432 |
---|---|
author | Babaahmadi-Rezaei, Hossein Kheirollah, Alireza Hesam, Saeed Ayashi, Saleh Aberumand, Mohammad Adel, Mohammad Hassan Zamanpour, Masoumeh Alasvand, Maryam Amozgari, Zohreh Noor-Behbahani, Mojgan Niknam, Zahra |
author_facet | Babaahmadi-Rezaei, Hossein Kheirollah, Alireza Hesam, Saeed Ayashi, Saleh Aberumand, Mohammad Adel, Mohammad Hassan Zamanpour, Masoumeh Alasvand, Maryam Amozgari, Zohreh Noor-Behbahani, Mojgan Niknam, Zahra |
author_sort | Babaahmadi-Rezaei, Hossein |
collection | PubMed |
description | BACKGROUND: Although the antioxidant properties of ginger have been revealed, there is little available information on the effectiveness of ginger on inflammatory disorders such as atherosclerosis. This study was carried out to examine the effect of ginger on improving the complication of atherosclerosis. METHODS: This study was a double-blind, placebo-controlled, randomized clinical trial conducted on patients with atherosclerosis. Participants in the ginger and control groups received 1600 mg of powdered ginger or placebo (wheat flour) in capsules daily for 8 weeks. Weight, body mass index (BMI), fasting blood sugar (FBS), cholesterol, triglyceride (TG), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), high-density lipoprotein (HDL), lipoprotein (a) [Lp(a)], high-sensitivity C-reactive protein (hs-CRP), and total anti-oxidant capacity (TAC) were assessed before and after the intervention. RESULTS: Ginger consumption in the intervention group significantly reduced serum Lp(a) level (27.25 ± 1.30 ng/ml vs. 23.57 ± 0.97 ng/ml) (P = 0.040) and also the level of hs-CRP in the intervention group was 1.90 ± 0.33 µg/ml and 1.24 ± 0.15 µg/ml (P = 0.010) before and after intervention, respectively, but the levels of Lp(a) and hs-CRP were not decreased significantly in the placebo group. The level of TAC in the ginger group was 0.71 ± 0.05 mM and after the trial was 0.57 ± 0.04 mM (P = 0.050); no significant differences were seen in TAC when ginger was administered at 1600 mg/daily for 60 days. Also the level of Lp(a) and hs-CRP but not TAC reduced significantly in ginger group compared to placebo group after intervention. CONCLUSION: This study showed that ginger had anti-atherosclerosis and anti-glycemic properties associated through a significant decreased Lp(a) and FBS in patients with atherosclerosis supplemented with ginger. |
format | Online Article Text |
id | pubmed-7867307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-78673072021-02-16 Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial Babaahmadi-Rezaei, Hossein Kheirollah, Alireza Hesam, Saeed Ayashi, Saleh Aberumand, Mohammad Adel, Mohammad Hassan Zamanpour, Masoumeh Alasvand, Maryam Amozgari, Zohreh Noor-Behbahani, Mojgan Niknam, Zahra ARYA Atheroscler Original Article BACKGROUND: Although the antioxidant properties of ginger have been revealed, there is little available information on the effectiveness of ginger on inflammatory disorders such as atherosclerosis. This study was carried out to examine the effect of ginger on improving the complication of atherosclerosis. METHODS: This study was a double-blind, placebo-controlled, randomized clinical trial conducted on patients with atherosclerosis. Participants in the ginger and control groups received 1600 mg of powdered ginger or placebo (wheat flour) in capsules daily for 8 weeks. Weight, body mass index (BMI), fasting blood sugar (FBS), cholesterol, triglyceride (TG), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), high-density lipoprotein (HDL), lipoprotein (a) [Lp(a)], high-sensitivity C-reactive protein (hs-CRP), and total anti-oxidant capacity (TAC) were assessed before and after the intervention. RESULTS: Ginger consumption in the intervention group significantly reduced serum Lp(a) level (27.25 ± 1.30 ng/ml vs. 23.57 ± 0.97 ng/ml) (P = 0.040) and also the level of hs-CRP in the intervention group was 1.90 ± 0.33 µg/ml and 1.24 ± 0.15 µg/ml (P = 0.010) before and after intervention, respectively, but the levels of Lp(a) and hs-CRP were not decreased significantly in the placebo group. The level of TAC in the ginger group was 0.71 ± 0.05 mM and after the trial was 0.57 ± 0.04 mM (P = 0.050); no significant differences were seen in TAC when ginger was administered at 1600 mg/daily for 60 days. Also the level of Lp(a) and hs-CRP but not TAC reduced significantly in ginger group compared to placebo group after intervention. CONCLUSION: This study showed that ginger had anti-atherosclerosis and anti-glycemic properties associated through a significant decreased Lp(a) and FBS in patients with atherosclerosis supplemented with ginger. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2020-07 /pmc/articles/PMC7867307/ /pubmed/33598035 http://dx.doi.org/10.22122/arya.v16i4.2011 Text en © 2020 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Babaahmadi-Rezaei, Hossein Kheirollah, Alireza Hesam, Saeed Ayashi, Saleh Aberumand, Mohammad Adel, Mohammad Hassan Zamanpour, Masoumeh Alasvand, Maryam Amozgari, Zohreh Noor-Behbahani, Mojgan Niknam, Zahra Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial |
title | Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial |
title_full | Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial |
title_fullStr | Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial |
title_full_unstemmed | Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial |
title_short | Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial |
title_sort | decreased lipoprotein (a) and serum high-sensitivity c-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: a randomized controlled trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867307/ https://www.ncbi.nlm.nih.gov/pubmed/33598035 http://dx.doi.org/10.22122/arya.v16i4.2011 |
work_keys_str_mv | AT babaahmadirezaeihossein decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial AT kheirollahalireza decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial AT hesamsaeed decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial AT ayashisaleh decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial AT aberumandmohammad decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial AT adelmohammadhassan decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial AT zamanpourmasoumeh decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial AT alasvandmaryam decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial AT amozgarizohreh decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial AT noorbehbahanimojgan decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial AT niknamzahra decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial |